AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced that additional biomarker analyses from the BATON- (Biomarker Assessment of Tivozanib in ONcology) CRC study will be presented at …
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced that it has received written feedback from the U.
EXACT Sciences Corporation (NASDAQ:EXAS) shares increased 2.51% to $28.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced the relocation of its corporate headquarters to One Broadway in Cambridge, Massachusetts, effective today.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock had an absolutely amazing day in the market yesterday.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is having an absolutely amazing day in the market today after it announced news that it is still hopeful with …
